Skip to content
WELCOME10 — 10% OFF YOUR FIRST ORDER  ·  FREE SHIPPING OVER $300 CAD  ·  COA ON REQUEST
Research Comparison9 min read

Semax vs Selank: Same Laboratory, Same Trick, Completely Different Ancestors

Both were built in the same Moscow institute using the identical three-residue stabilisation trick — which makes them look like siblings. One descends from a stress hormone, the other from an antibody fragment. Here is what that actually changes.

semax vs selankselank semax comparisoncognitive research peptides canadapro-gly-pro peptide stabilitysemax bdnf researchresearch peptides canadasemax 10ml nasal spraybuy semax 10ml nasal spray canadaselank 10ml nasal spraybuy selank 10ml nasal spray canada
By Popular PeptidesPublished Updated
  • Semax and Selank share a Pro-Gly-Pro stabilising tail from the same Moscow engineering programme but descend from unrelated parents — Semax from ACTH(4-7), Selank from the immune peptide tuftsin.
  • Pro-Gly-Pro blocks aminopeptidase (enzymatic) clearance in biological media; it gives no protection against oxidation in a storage vial — a commonly conflated distinction.
  • Their literatures diverge: Semax is studied mainly in BDNF and neuroprotection (ischemia), Selank mainly in anxiolytic GABA/serotonin models, plus an immune-signalling thread.
  • The bench difference is sharper than the mechanism: Semax has an oxidation-prone N-terminal methionine (needs light protection); Selank has no Met/Cys/Trp but its positive charge causes adsorption to glass and plastic (needs low-bind labware).
  • Both are supplied as 10 ml nasal-spray research formats matching the published intranasal route; research use only, not for human or veterinary use.

Line up the sequences of Semax and Selank and you will notice the same three residues sitting at the end of both: Pro-Gly-Pro. It is not a coincidence, and it is not a shared mechanism. It is a signature — the fingerprint of a single peptide-engineering programme at the Institute of Molecular Genetics in Moscow, applied to two entirely unrelated parent molecules.

Understanding that shared tail, and what it does and does not do, is the fastest way to understand both compounds.

The problem Pro-Gly-Pro was invented to solve

Short peptides are fragile in biological media for a specific reason: aminopeptidases chew them from the N-terminus, and most sequences offer no resistance. A promising four-residue fragment can be gone in seconds.

Proline is the exception. Its side chain loops back and bonds to its own backbone nitrogen, creating a rigid ring that peptidases handle badly. Appending Pro-Gly-Pro to a fragment therefore does something elegant: it caps the molecule against enzymatic clearance without altering the active region.

The Moscow group applied this same trick twice, to two molecules with nothing else in common.

**Semax** took ACTH(4-7) — a four-residue fragment of adrenocorticotropic hormone, the stress hormone — and appended Pro-Gly-Pro. The fragment was chosen specifically because it carries the neurotropic properties of interest without the corticotropic activity of the full hormone.

**Selank** took tuftsin — Thr-Lys-Pro-Arg, an immunomodulatory tetrapeptide released from the Fc region of immunoglobulin G, named for Tufts University where it was characterised — and appended the same three residues.

One descends from a stress hormone. The other from an antibody. Same engineering, unrelated lineage.

SemaxSelank
Parent moleculeACTH(4-7) — adrenocorticotropic hormone fragmentTuftsin — immunomodulatory tetrapeptide from IgG
SequenceMet-Glu-His-Phe-Pro-Gly-ProThr-Lys-Pro-Arg-Pro-Gly-Pro
Molecular weight813.94 g/mol751.86 g/mol
CAS number80714-61-0129954-34-3
Research focusBDNF expression, neuroprotection under ischemiaAnxiolytic models, GABA and serotonin pathways
Key residue liabilityN-terminal methionine — oxidation-proneNone — no Met, Cys or Trp at all
Practical handling riskLight and oxygen exposureAdsorption to glass and untreated plastic
Working window2–3 weeks at 2–8 °C, protected from light3–4 weeks at 2–8 °C

Where the research literatures separate

**Semax** is studied predominantly in neuroprotection. The most-cited finding is upregulation of brain-derived neurotrophic factor, and there is a substantial Russian literature examining the compound in cerebral ischemia models, alongside behavioural work on attention and memory consolidation.

**Selank** is studied predominantly in anxiolytic models. Published work examines interaction with GABAergic and serotonergic systems, notably without the sedation associated with benzodiazepine-class compounds — a distinction that is part of why the compound drew research attention in the first place. Its tuftsin ancestry also gives it a thread of immune-signalling research that Semax has no equivalent for.

So: same design philosophy, divergent literatures. See the full Semax vs Selank comparison reference for the complete side-by-side, or the individual notes on Semax and BDNF neuroprotection research and Selank anxiety research.

The bench difference is sharper than the mechanism difference

Here is where the two compounds genuinely stop resembling each other, and it comes down to residue composition rather than pharmacology.

**Semax carries a methionine at the N-terminus.** Methionine is the most oxidation-prone proteinogenic side chain, and in Semax it occupies the exposed terminal position on the very end that carries the pharmacophore. Semax therefore needs genuine light protection — amber vials or dark storage — and its working window is shorter as a result.

**Selank contains no methionine, no cysteine, and no tryptophan.** None of the standard oxidation routes apply to it at all. It is one of the more chemically forgiving peptides in the reference library, with a correspondingly longer window.

But Selank has a different problem, and it is a physical one rather than a chemical one. Lysine and arginine give it a strong net positive charge at working pH, and negatively charged glass and untreated plastic surfaces bind cationic peptides readily. At dilute working concentrations, adsorption can remove a meaningful fraction of your material from solution. That looks exactly like poor potency in a result, and it is nothing of the kind.

The countermeasures are therefore completely different: Semax needs darkness, Selank needs low-bind labware. Applying the wrong one to the wrong compound gets you nothing.

Detail: Semax storage and Semax stability; Selank storage and Selank stability.

A common misreading of what Pro-Gly-Pro does

The Pro-Gly-Pro tail protects against *enzymatic* degradation in biological media. It provides no protection whatsoever against *oxidation* in a storage vial. These are different failure modes with different countermeasures, and conflating them is one of the more common errors made with both compounds.

Put plainly: Semax is engineered to survive an organism. It is not engineered to survive a sunny bench.

The nasal-spray format, explained

Both compounds are widely available in a 10 mL nasal-spray research format, which sometimes reads as a formulation choice. It is not — it reflects the published methodology. Intranasal delivery is a long-standing route in the literature for compounds studied in central nervous system models, and the original Russian research programmes used it. The research format mirrors the route used in the studies being referenced.

Choosing between them for a study design

  • **Measuring neurotrophic signalling, BDNF expression, or neuroprotective endpoints?** Semax sits in the middle of that literature. Budget for light-protected handling.
  • **Measuring anxiety-model behaviour or GABA/serotonin pathway interaction?** Selank is the better-populated choice, and it is chemically the easier of the two to store — provided you use low-bind labware for dilutions.
  • **Running both?** They are frequently studied together, which is why they appear in the same research stack. See the note on the Limitless research stack.

Reconstitution presets: Semax calculator and Selank calculator. Both dissolve essentially instantly — at these molecular weights there is no solvent difficulty to manage.

Frequently asked questions

What does the Pro-Gly-Pro tail actually do?

It blocks aminopeptidase cleavage. Proline bonds are handled poorly by peptidases, so capping a fragment with Pro-Gly-Pro dramatically extends its persistence in biological media without altering the active region. Both Semax and Selank use it, which is why they look structurally related despite descending from unrelated parents.

Is Semax related to ACTH, and does it share ACTH's hormonal activity?

It derives from residues 4–7 of ACTH but does not carry the corticotropic activity of the full hormone. The fragment was selected precisely to separate the neurotropic properties studied in the literature from the endocrine activity of the parent molecule.

Why is Selank less oxidation-sensitive than Semax?

Residue composition, nothing more. Semax has an N-terminal methionine — the single most oxidation-prone side chain. Selank's sequence contains no methionine, cysteine or tryptophan, so that degradation route simply does not exist for it.

Why does Selank need low-bind labware?

Its lysine and arginine residues give it a strong net positive charge, and negatively charged glass and untreated plastic bind cationic peptides readily. At dilute concentrations this adsorptive loss can be substantial — and because it removes material rather than degrading it, it produces results that look like low potency.

Can Semax and Selank be studied together?

They are frequently examined in parallel in cognitive research designs, which is why they are commonly stocked together. Their mechanisms and literatures are distinct rather than overlapping, so running both addresses different questions rather than duplicating one.

*Research use only. Semax and Selank are supplied strictly for in vitro laboratory research and are not intended for human or veterinary use, consumption, diagnosis, or therapy. This article summarizes published preclinical literature and laboratory handling data; it is not medical advice and not a claim of efficacy.*

Where to get these

Compounds referenced in this guide:

Everything below ships domestically from Vancouver, BC — tracked, insured, discreetly packaged, typically 2 to 5 business days. Nothing crosses a border, so nothing gets held at one. Purity and identity are confirmed per batch by an independent lab, and you can pull the certificate for your exact vial by lot number. Canadian dollars, free shipping over $300 CAD.

Browse every published lab result before you order, or check the reference library for molecular data on each compound.

Every batch we sell is independently third-party tested, with the full Certificate of Analysis published and checkable by lot number.